Delta analysis of posttransplantation tubulointerstitial damage

Transplantation

Volumn 78, Issue 3, 2004, Pages 434-441

  Nankivell, Brian J ^a,c   Borrows, Richard J ^a,b   Fung, Caroline L S ^c   O'Connell, Philip J ^a   Chapman, Jeremy R ^a   Allen, Richard D M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ST MARY S HOSPITAL   (United Kingdom)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Chronic allograft nephropathy; Chronic interstitial fibrosis; Kidney transplantation; Tubular atrophy

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ACUTE KIDNEY TUBULE NECROSIS; ARTICLE; CELL INFILTRATION; CHRONIC DISEASE; CORRELATION ANALYSIS; DELTA ANALYSIS; DISEASE SEVERITY; EVALUATION; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STATISTICAL ANALYSIS;

ADULT; ATROPHY; BIOPSY, NEEDLE; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; PANCREAS TRANSPLANTATION; TREATMENT OUTCOME;

EID: 4143120048     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000128613.74683.D9     Document Type: Article

References (28)

1. Nankivell BJ, Burrows RJ, Fung CL-S, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2324-2331.
2. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
3. Isoniemi H, Taskinen E, Hayry P. Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 1994; 58: 1195-1198.
4. Nicholson ML, McCulloch TA, Harper SJ, et al. Early measurement of interstitial fibrosis predicts long-term renal function and graft survival in renal transplantation. Br J Surg 1996; 83: 1082-1085.
5. Dimeny E, Wahlberg J, Larsson E, et al. Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection? Clin Transplant 1995; 9: 79-84.
6. Kasiske BL, Kalil RS, Lee HS, et al. Histopathologic findings associated with a chronic, progressive decline in renal allograft function. Kidney Int 1991; 40: 514-524.
7. Nankivell BJ, Fenton-Lee CA, Kuypers DR, et al. Effect of histological damage on long-term kidney transplant outcome. Transplantation 2001; 71: 515-523.
8. Cosio FG, Pelletier RP, Sedmak DD, et al. Pathologic classification of chronic allograft nephropathy: pathogenic and prognostic implications. Transplantation 1999; 67: 690-696.
9. Seron D, Moreso F, Bover J, et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997; 51: 310-316.
10. Bohle A, Wehrmann M, Bogenschutz O, et al. The long-term prognosis of the primary glomerulonephritides: a morphological and clinical analysis of 1747 cases. Pathol Res Pract 1992; 188: 908-924.
11. Rush D, Jeffery J, Trpkov K, et al. Effect of subclinical rejection on renal allograft histology and function at 6 months. Transplant Proc 1996; 28: 494-495.
12. Mihatsch MJ, Ryffel B, Gudat F. The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int Suppl 1995; 52: S65-S69.
13. Waller JR, Nicholson ML. Molecular mechanisms of renal allograft fibrosis. Br J Surg 2001; 88: 1429-1441.
14. Burdick JF, Beschorner WE, Smith WJ, et al. Characteristics of early routine renal allograft biopsies. Transplantation 1984; 38: 679-684.
15. Grimm PC, Nickerson P, Gough J, et al. Quantitation of allograft fibrosis and chronic allograft nephropathy. Pediatr Transplant 1999; 3: 257-270.
16. Nickerson P, Jeffery J, Gough J, et al. Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant. J Am Soc Nephrol 1998; 9: 482-487.
17. Lipman ML, Shen Y, Jeffery JR, et al. Immune-activation gene expression in clinically stable renal allograft biopsies: molecular evidence for subclinical rejection. Transplantation 1998; 66: 1673-1681.
18. Rush D, Nickerson P, Gough J, et al. Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 1998; 9: 2129-2134.
19. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999; 10: 167-181.
20. Yilmaz S, Tomlanovich S, Mathew T, et al. Protocol core needle biopsy and histologic chronic allograft damage index (CADI) as surrogate end point for long-term graft survival in multicenter studies. J Am Soc Nephrol. 2003; 14: 773-779.
21. Jain S, Bicknell GR, Nicholson ML. Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury. Br J Surg 2000; 87: 1563-1568.
22. Cuhaci B, Kumar MS, Bloom RD, et al. Transforming growth factor-beta levels in human allograft chronic fibrosis correlate with rate of decline in renal function. Transplantation 1999; 68: 785-790.
23. Baboolal K, Jones GA, Janezic A, et al. Molecular and structural consequences of early renal allograft injury. Kidney Int 2002; 61: 686-696.
24. Bicknell GR, Williams ST, Shaw JA, et al. Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants. Br J Surg 2000; 87: 1569-1575.
25. Shihab FS, Bennett WM, Tanner AM, et al. Angiotensin II blockade decreases TGF-beta 1 and matrix proteins in cyclosporine nephropathy. Kidney Int 1997; 52: 660-673.
26. Azuma H, Binder J, Heemann U, et al. Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation 1995; 59: 460-466.
27. Badid C, Vincent M, McGregor B, et al. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int 2000; 58: 51-61.
28. Remuzzi G, Perico N. Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int Suppl 1995; 52: S70-S74.